Schroeder FH - Search Results

1

Monoclonal antibody Ki-67 defined growth fraction in benign prostatic hyperplasia and prostatic cancer.

Gallee MP, Visser-de Jong E, ten Kate FJ, Schroeder FH, Van der Kwast TH. Gallee MP, et al. Among authors: schroeder fh. J Urol. 1989 Nov;142(5):1342-6. doi: 10.1016/s0022-5347(17)39094-8. J Urol. 1989. PMID: 2478729

2

Morphometrically estimated variation in nuclear size. A useful tool in grading prostatic cancer.

Blom JH, Ten Kate FJ, Schroeder FH, van der Heul RO. Blom JH, et al. Among authors: schroeder fh. Urol Res. 1990;18(2):93-9. doi: 10.1007/BF00302467. Urol Res. 1990. PMID: 2187298

3

Determination of the proliferative fraction of a transplantable, hormone-dependent, human prostatic carcinoma (PC-82) by monoclonal antibody Ki-67: potential application for hormone therapy monitoring.

Gallee MP, van Steenbrugge GJ, ten Kate FJ, Schroeder FH, van der Kwast TH. Gallee MP, et al. Among authors: schroeder fh. J Natl Cancer Inst. 1987 Dec;79(6):1333-40. J Natl Cancer Inst. 1987. PMID: 3320449

4

Variation of prostate-specific antigen expression in different tumour growth patterns present in prostatectomy specimens.

Gallee MP, Visser-de Jong E, van der Korput JA, van der Kwast TH, ten Kate FJ, Schroeder FH, Trapman J. Gallee MP, et al. Among authors: schroeder fh. Urol Res. 1990;18(3):181-7. doi: 10.1007/BF00295844. Urol Res. 1990. PMID: 1697709 Free article.

5

Androgen receptor heterogeneity in human prostatic carcinomas visualized by immunohistochemistry.

de Winter JA, Trapman J, Brinkmann AO, Boersma WJ, Mulder E, Schroeder FH, Claassen E, van der Kwast TH. de Winter JA, et al. Among authors: schroeder fh. J Pathol. 1990 Apr;160(4):329-32. doi: 10.1002/path.1711600409. J Pathol. 1990. PMID: 2193135

6

Effects of long-term catheter implantation on the contractile and histological properties of the canine bladder.

Hoekstra JW, Griffiths DJ, Tauecchio EA, Schroeder FH, ten Kate FJ. Hoekstra JW, et al. Among authors: schroeder fh. J Urol. 1985 Apr;133(4):709-12. doi: 10.1016/s0022-5347(17)49166-x. J Urol. 1985. PMID: 3884848

7

Evaluation of prostate-specific antigen and prostatic acid phosphatase in untreated prostatic carcinoma and benign prostatic hyperplasia.

Bogdanowicz JF, Bentvelsen FM, Oosterom R, Schroeder FH. Bogdanowicz JF, et al. Among authors: schroeder fh. Scand J Urol Nephrol Suppl. 1991;138:97-103. Scand J Urol Nephrol Suppl. 1991. PMID: 1723815

8

Treatment of benign prostatic hyperplasia by androgen deprivation: effects on prostate size and urodynamic parameters.

Bosch RJ, Griffiths DJ, Blom JH, Schroeder FH. Bosch RJ, et al. Among authors: schroeder fh. J Urol. 1989 Jan;141(1):68-72. doi: 10.1016/s0022-5347(17)40591-x. J Urol. 1989. PMID: 2462067 Clinical Trial.

9

Surgical treatment of locally advanced (T3) prostatic carcinoma: early results.

Bosch RJ, Kurth KH, Schroeder FH. Bosch RJ, et al. Among authors: schroeder fh. J Urol. 1987 Oct;138(4):816-22. doi: 10.1016/s0022-5347(17)43383-0. J Urol. 1987. PMID: 3656537

10

Androgens and androgen-receptors in prostate tissue from patients with benign prostatic hyperplasia: effects of cyproterone acetate.

de Jong FH, Reuvers PJ, Bolt-de Vries J, Mulder E, Blom JH, Schroeder FH. de Jong FH, et al. Among authors: schroeder fh. J Steroid Biochem Mol Biol. 1992 Mar;42(1):49-55. doi: 10.1016/0960-0760(92)90010-g. J Steroid Biochem Mol Biol. 1992. PMID: 1373073

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

68 results

Search Page

Filters